Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation

By Kaden J.   Strobelt V.   May G.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4011-4014

Elsevier

Access to resources Recommend Favorite

Intraoperative T-Cell Depletion Prior to Completion of Anastomoses by High-Dose Single ATG Bolus as a New Approach to Improve Long-Term Results After Kidney Transplantation

By Kaden J.   May G.   Strobelt V.   Groth J.   Muller P.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 344-347

Elsevier

Access to resources Recommend Favorite

Low-Dose OKT3 Treatment for Rejection/Induction in Kidney and Kidney-Pancreas Transplantation

By Desai D.M.   Scandling J.D.   Knoppel C.   Dafoe D.C.   Alfrey E.J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1552-1554

Elsevier

Access to resources Recommend Favorite

Influence of the type of renal replacement therapy on peritonitis rate after simultaneous pancreas kidney transplantation

By Malaise J.   Squifflet J.P.   Van Ophem D.   EUROSPK Study Group  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2823-2823

Elsevier

Access to resources Recommend Favorite

Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results

By Samsel R.   Rowinski W.   Chmura A.   Wlodarczyk Z.   Wyzgal J.   Cieciura T.   Lagiewska B.   Pliszczynski J.   Korczak G.   Paczek L.   Walaszewski J.   Lao M.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2952-2954

Elsevier

Access to resources Recommend Favorite